Improving Powder Flow Properties of a Direct Compression Formulation Using a Two-Step Glidant Mixing Process
-
- Abe Hidaka
- Pharmaceutical Research Department, Mitsubishi Tanabe Pharma Corporation
-
- Yasui Shinichiro
- Pharmaceutical Research Department, Mitsubishi Tanabe Pharma Corporation
-
- Kuwata Aya
- Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University
-
- Takeuchi Hirofumi
- Laboratory of Pharmaceutical Engineering, Gifu Pharmaceutical University
この論文をさがす
抄録
To improve powder flow of a high-dose direct compression formulation (drug content 30%), we compared a two-step operation for mixing glidants with a conventional one-step glidant mixing process. This two-step mixing operation was studied with two kinds of mixtures; an active pharmaceutical ingredient (API)-glidant combination and a direct compression excipient-glidant combination. The two-step operation permitted the selection of the optimum glidant type and concentration in each glidant-mixing procedure even though the formulation had different powder properties such as micronized API and enlarged direct compression vehicles, whereas the conventional approaches forced the selection of a certain glidant type and concentration at one-step mixing. The addition of 0.5% nonporous silica markedly improved API flow. In contrast, 1.0% porous silica was the appropriate glidant to enhance excipient flow at direct compression excipient-glidant mixing. The two-step operation dominantly enhanced powder flow when the appropriate API-glidant mixture and the suitable direct compression excipients-glidant mixture were blended compared to the one-step operation with its optimum glidant concentration. The results showed that the angle of repose was 43° and the critical orifice diameter was 10 mm in the two-step operation, whereas it was 47° and 16 mm in the one-step operation. The two-step operation of glidant mixing enhanced powder flow of the high-dose direct compression formulation compared with the one-step operation. The two-step operation eliminates the bottleneck of powder flow and allows direct compression to be more worth applying for formulation and process development trials.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 57 (7), 647-652, 2009
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679147010944
-
- NII論文ID
- 130000124361
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- HANDLE
- 20.500.12099/44496
-
- NDL書誌ID
- 10264495
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可